Cytokeratin 18 fragment in liver inflammation and fibrosis: Systematic review and meta-analysis
- 19 January 2025
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 569, 120147
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation (2020M683128)
- Natural Science Foundation of Guangdong Province (2022A1515012369)
- National Natural Science Foundation of China (82100648, 81870404, 82370587)
This publication has 80 references indexed in Scilit:
- Serum keratin‐18 detects hepatic inflammation and predicts progression in compensated alcohol‐associated liver diseaseHepatology Communications, 2022
- Attacking the public health crisis of hepatocellular carcinoma at its rootsHepatology, 2022
- Health disparities in chronic liver diseaseHepatology, 2022
- The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic SteatohepatitisJournal of Magnetic Resonance Imaging, 2021
- The application of cytokeratin-18 as a biomarker for drug-induced liver injuryArchives of Toxicology, 2021
- Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liverHepatology, 2016
- Prospective Biopsy-Controlled Evaluation of Cell Death Biomarkers for Prediction of Liver Fibrosis and Nonalcoholic SteatohepatitisHepatology, 2011
- Noninvasive Assessment of Liver Disease Severity With Liver Fat Score and Ck-18 in Nafld: Prognostic Value of Liver Fat Equation Goes Beyond Hepatic Fat EstimationHepatology, 2010
- Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic SteatohepatitisHepatology, 2009
- In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver diseaseHepatology, 2006